1. Home
  2. TEI vs PROF Comparison

TEI vs PROF Comparison

Compare TEI & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TEI

Templeton Emerging Markets Income Fund Inc.

HOLD

Current Price

$5.89

Market Cap

324.9M

Sector

Finance

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.19

Market Cap

270.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEI
PROF
Founded
1993
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
324.9M
270.7M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
TEI
PROF
Price
$5.89
$6.19
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
234.8K
352.4K
Earning Date
01-01-0001
03-05-2026
Dividend Yield
10.51%
N/A
EPS Growth
N/A
25.89
EPS
N/A
1.41
Revenue
N/A
$16,098,000.00
Revenue This Year
N/A
$115.41
Revenue Next Year
N/A
$60.63
P/E Ratio
N/A
$4.47
Revenue Growth
N/A
50.73
52 Week Low
$4.78
$3.90
52 Week High
$7.00
$8.95

Technical Indicators

Market Signals
Indicator
TEI
PROF
Relative Strength Index (RSI) 24.12 52.14
Support Level $5.90 $5.81
Resistance Level $6.18 $7.18
Average True Range (ATR) 0.12 0.47
MACD -0.03 0.11
Stochastic Oscillator 24.28 74.11

Price Performance

Historical Comparison
TEI
PROF

About TEI Templeton Emerging Markets Income Fund Inc.

Templeton Emerging Markets Income Fund is a closed-end fund. It seeks high, current income, with a secondary goal of capital appreciation, by investing, under normal market conditions. The company's investment portfolio includes Foreign Government and Agency Securities; Quasi-Sovereign and Corporate Bonds; Common Stocks and Other Equity Interests, and Short-Term Investments, and Money Market Funds.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: